SLI
1.986,02
PKT
+13,07
PKT
+0,66
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.04.24 | Givaudan Reduce | Baader Bank | |
| 11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.24 | UBS Outperform | RBC Capital Markets | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 04.04.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital | |
| 02.04.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 02.04.24 | Richemont Buy | UBS AG | |
| 02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 28.03.24 | Richemont Buy | Jefferies & Company Inc. | |
| 28.03.24 | UBS Outperform | RBC Capital Markets | |
| 28.03.24 | Richemont Sector Perform | RBC Capital Markets | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 27.03.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.03.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 26.03.24 | Nestlé Buy | Deutsche Bank AG | |
| 26.03.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 25.03.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.24 | UBS Outperform | RBC Capital Markets |